| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
| A1 | 1 | 21 | F | Uterus | Adenomatoid hyperplasia of endometrium | * | * | * | Normal |
| A2 | 2 | 21 | F | Uterus | Normal endometrium tissue | * | * | * | Normal |
| A3 | 3 | 18 | F | Uterus | Normal endometrium tissue | * | * | * | Normal |
| A4 | 4 | 35 | F | Uterine cervix | Cancer adjacent cervical canals tissue (hyperplasia) | * | * | * | NAT |
| A5 | 5 | 72 | F | Uterine cervix | Cancer adjacent cervix tissue with saccular ectasia | * | * | * | NAT |
| A6 | 6 | 65 | F | Uterine cervix | Cancer adjacent cervix tissue | * | * | * | NAT |
| A7 | 7 | 21 | F | Skeletal muscle | Normal skeletal muscle tissue | * | * | * | Normal |
| A8 | 8 | 49 | F | Skeletal muscle | Cancer adjacent skeletal muscle tissue | * | * | * | NAT |
| A9 | 9 | 47 | M | Skeletal muscle | Normal skeletal muscle tissue | * | * | * | Normal |
| B1 | 10 | 50 | F | Skin | Cancer adjacent skin tissue | * | * | * | NAT |
| B2 | 11 | 37 | M | Skin | Normal skin tissue | * | * | * | Normal |
| B3 | 12 | 18 | F | Skin | Normal skin tissue of head | * | * | * | Normal |
| B4 | 13 | 33 | M | Nerve | Normal peripheral nerve tissue | * | * | * | Normal |
| B5 | 14 | 35 | M | Nerve | Normal peripheral nerve tissue | * | * | * | Normal |
| B6 | 15 | 35 | M | Nerve | Normal peripheral nerve tissue | * | * | * | Normal |
| B7 | 16 | 22 | M | Lung | Normal mesothelial tissue | * | * | * | Normal |
| B8 | 17 | 27 | F | Cardiac pericardium | Normal mesothelial tissue | * | * | * | Normal |
| B9 | 18 | 47 | M | Lung | Normal lung and mesothelium tissue | * | * | * | Normal |
| C1 | 19 | 41 | F | Cerebrum | Glioblastoma | 3--4 | * | * | Malignant |
| C2 | 20 | 65 | F | Cerebrum | Atypical meningioma | * | * | * | Malignant |
| C3 | 21 | 15 | F | Cerebrum | Malignant ependymoma | * | * | * | Malignant |
| C4 | 22 | 39 | F | Cerebrum | Oligodendroglioma | 2 | * | * | Malignant |
| C5 | 23 | 63 | F | Ovary | Serous adenocarcinoma | 3 | T2N0M0 | II | Malignant |
| C6 | 24 | 29 | F | Ovary | Adenocarcinoma | 2 | T3N0M0 | III | Malignant |
| C7 | 25 | 12 | F | Pancreas | Islet cell tumor | * | * | * | Malignant |
| C8 | 26 | 64 | M | Pancreas | Adenocarcinoma | 2 | T3N0M0 | II | Malignant |
| C9 | 27 | 32 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
| D1 | 28 | 30 | M | Testis | Embryonal carcinoma | * | T2N0M0 | I | Malignant |
| D2 | 29 | 33 | F | Thyroid | Medullary carcinoma | * | T3N0M0 | II | Malignant |
| D3 | 30 | 46 | F | Thyroid | Papillary carcinoma | * | T4N0M0 | III | Malignant |
| D4 | 31 | 43 | F | Breast | Invasive ductal carcinoma | 1 | T2N1M0 | IIA | Malignant |
| D5 | 32 | 48 | F | Breast | Intraductal carcinoma | * | TisN0M0 | 0 | Malignant |
| D6 | 33 | 58 | F | Breast | Invasive ductal carcinoma | 1--2 | T2N1M0 | IIB | Malignant |
| D7 | 34 | 21 | M | Spleen | Diffuse B-cell lymphoma | * | * | * | Malignant |
| D8 | 35 | 61 | M | Lung | Small cell undifferentiated carcinoma | * | T2N0M0 | I | Malignant |
| D9 | 36 | 66 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | I | Malignant |
| E1 | 37 | 42 | M | Lung | Adenocarcinoma | 2--3 | T2N0M0 | IB | Malignant |
| E2 | 38 | 67 | M | Esophagus | Neuroendocrine carcinoma | * | T2N1M0 | IIA | Malignant |
| E3 | 39 | 63 | M | Esophagus | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
| E4 | 40 | 73 | F | Stomach | Signet-ring cell carcinoma | * | T2N1M0 | II | Malignant |
| E5 | 41 | 64 | F | Intestine | Adenocarcinoma | 3 | T4N0M0 | II | Malignant |
| E6 | 42 | 71 | F | Intestine | Stromal sarcoma | * | T2N0M0 | IIB G2 | Malignant |
| E7 | 43 | 72 | F | Colon | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
| E8 | 44 | 54 | M | Colon | Interstitialoma | * | T2N0M0 | IIB G2 | Malignant |
| E9 | 45 | 36 | M | Rectum | Adenocarcinoma | 2 | T2N0M0 | I | Malignant |
| F1 | 46 | 63 | F | Rectum | Moderate malignant interstitialoma | * | T2N0M0 | IIB G2 | Malignant |
| F2 | 47 | 55 | F | Liver | Hepatocellular carcinoma | 1--2 | T3N0M0 | IIIA | Malignant |
| F3 | 48 | 17 | F | Liver | Hepatoblastoma | * | * | * | Malignant |
| F4 | 49 | 60 | M | Kidney | Clear cell carcinoma | 1 | T2N0M0 | II | Malignant |
| F5 | 50 | 80 | M | Prostate | Adenocarcinoma (Gleason grade:4 Gleason score:4+5) | 3 | T4N1M1c | IV | Malignant |
| F6 | 51 | 77 | M | Prostate | Adenocarcinoma (Gleason grade:3 Gleason score:3+4) | 2--3 | T2N0M0 | II | Malignant |
| F7 | 52 | 33 | F | Uterus | Leiomyoma | * | T2N0M0 | IB G1 | Malignant |
| F8 | 53 | 50 | F | Uterus | Adenocarcinoma | 1--2 | T1bN0M0 | IB | Malignant |
| F9 | 54 | 50 | F | Uterus | Clear cell carcinoma of endometrium | - | T2bN0M0 | IIB | Malignant |
| G1 | 55 | 36 | F | Uterine cervix | Squamous cell carcinoma | * | T1bN0M0 | IB | Malignant |
| G2 | 56 | 49 | F | Uterine cervix | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant |
| G3 | 57 | 20 | F | Striated muscle | Embryonal rhabdomyosarcom of left leg | * | T1aN0M0 | IA | Malignant |
| G4 | 58 | 70 | F | Rectum | Malignant melanoma | * | T4N0M0 | IIIB | Malignant |
| G5 | 59 | 61 | M | Skin | Basal cell carcinoma of left face | * | T2N0M0 | II | Malignant |
| G6 | 60 | 64 | M | Skin | Squamous cell carcinoma of chest wall | 2 | T3N0M0 | II | Malignant |
| G7 | 61 | 59 | M | Back | Neurofibroma | * | * | * | Malignant |
| G8 | 62 | 1 | F | Retroperitoneum | Neuroblastoma | * | T2bN0M0 | IIIB | Malignant |
| G9 | 63 | 60 | M | Abdominal cavity | Malignant mesothelioma | * | T2N0M0 | IIB G2 | Malignant |
| H1 | 64 | 49 | M | Mediastinum | Diffuse B-cell lymphoma of lymph node | * | * | * | Malignant |
| H2 | 65 | 50 | F | Lymph node | Diffuse B cell lymphoma of right thigh | * | * | * | Malignant |
| H3 | 66 | 27 | M | Lymph node | Hodgkin's lymphoma of left groin | * | * | * | Malignant |
| H4 | 67 | 19 | F | Pelvic cavity | Anaplastic large cell lymphoma | * | * | * | Malignant |
| H5 | 68 | 76 | M | Bladder | Transitional cell carcinoma | 2 | T3aN0M0 | III | Malignant |
| H6 | 69 | 62 | M | Bladder | Low grade malignant leiomyosarcoma | * | T2bN0M0 | IB G1 | Malignant |
| H7 | 70 | 7 | F | Bone | Osteosarcoma of right femur | * | T2N0M0 | IIIB | Malignant |
| H8 | 71 | 48 | F | Retroperitoneum | Spindle cell rhabdomyosarcoma | * | T2N0M0 | IIB | Malignant |
| H9 | 72 | 60 | F | Smooth muscle | Moderate malignant leiomyosarcoma of left buttock | * | T2bN0M0 | IIIB G3 | Malignant |
| Tissue Marker |
